Analysis of pregnancy outcome and decline of anti-Muellerian hormone after laparoscopic cystectomy for ovarian endometriomas

Aim Excision of ovarian endometrioma (OE) may induce the reduction of ovarian reserve. We evaluated pregnancy outcomes after laparoscopic cystectomy (LC), and the pre- and postoperative levels of anti-Muellerian hormone (AMH) to consider the ovarian reserve. Methods We enrolled 40 women with OE and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of obstetrics and gynaecology research 2016-11, Vol.42 (11), p.1534-1540
Hauptverfasser: Taniguchi, Fuminori, Sakamoto, Yasuko, Yabuta, Yuko, Azuma, Yukihiro, Hirakawa, Eriko, Nagira, Kei, Uegaki, Takashi, Deura, Imari, Hata, Koukichi, Harada, Tasuku
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aim Excision of ovarian endometrioma (OE) may induce the reduction of ovarian reserve. We evaluated pregnancy outcomes after laparoscopic cystectomy (LC), and the pre- and postoperative levels of anti-Muellerian hormone (AMH) to consider the ovarian reserve. Methods We enrolled 40 women with OE and 16 women with benign ovarian tumors who hoped to have a child and who underwent LC. To evaluate the ovarian reserve of 40 patients (OE group, n = 24; non-OE group, n = 16), we measured serum AMH levels before and after the surgery. Results In the 40 women who underwent LC for OE, the cumulative pregnancy rate was 50%. Prior to the cystectomy, serum AMH levels in the OE group, especially in patients over the age of 35, were significantly lower than those in the non-OE group. Rate of decline in serum AMH in the OE group was significant compared with that in the non-OE group 6 months after surgery. In patients over the age of 35 in the OE group, AMH levels 1 year after surgery decreased noticeably. Conclusion LC for OE could be a preferred surgical approach, but effective therapeutic strategies will have to be developed to prevent damage to the ovarian reserve, especially for older patients.
ISSN:1341-8076
1447-0756
DOI:10.1111/jog.13081